From: Psychological evaluation and support in COVID-19 critically ill patients: a feasibility study
β | [95%] CI | p value | |
---|---|---|---|
Predicting insomnia in follow-up | |||
History of sleep disorders | 4.24 | [− 0.54;9.08] | 0.082 |
Acute respiratory distress syndrome | 0.099 | ||
Mild | Reference | Reference | |
Moderate | 1.32 | [− 2.46;5.09] | |
Severe | 4.87 | [0.35;9.34] | |
Cumulative dose of morphine (for 1000 units) | 0.74 | [− 0.06;1.53] | 0.069 |
Cumulative dose of midazolam (for 100 units) | 1.41 | [0.44;2.39] | 0.007 |
Cumulative dose of clonidine (for 1 unit) | 1.29 | [0.24;2.36] | 0.020 |
Maximal dose of norepinephrine | − 2.78 | [− 11.5;5.98] | 0.520 |
Length of ICU stay (for 10 days) | 1.02 | [0.14;1.90] | 0.025 |
Predicting anxiety in follow-up | |||
History of sleep disorders | 0.98 | [− 1.87;3.78] | 0.488 |
Acute respiratory distress syndrome | 0.206 | ||
Mild | Reference | Reference | |
Moderate | 0.75 | [− 1.39;2.94] | |
Severe | 2.36 | [− 0.30;4.97] | |
Cumulative dose of morphine (for 1000 units) | 0.15 | [− 0.45;0.76] | 0.612 |
Cumulative dose of midazolam (for 100 units) | 0.02 | [− 0.12;0.07] | 0.537 |
Cumulative dose of clonidine (for 1 unit) | 0.43 | [− 0.12;0.98] | 0.118 |
Maximal dose of norepinephrine | − 2.61 | [− 7.64;2.44] | 0.301 |
Length of ICU stay (for 10 days) | 0.46 | [− 0.07;0.99] | 0.091 |
Predicting depression in follow-up | |||
History of sleep disorders | 1.19 | [− 2.09;4.41] | 0.464 |
Acute respiratory distress syndrome | 0.823 | ||
Mild | Reference | Reference | |
Moderate | 0.75 | [− 1.89;3.42] | |
Severe | 0.81 | [− 2.43;3.99] | |
Cumulative dose of morphine (for 1000 units) | 0.05 | [− 0.60;0.69] | 0.883 |
Cumulative dose of midazolam (for 100 units) | 0.02 | [− 0.05;0.09] | 0.588 |
Cumulative dose of clonidine (for 1 unit) | 0.57 | [0.11;1.03] | 0.019 |
Maximal dose of norepinephrine | − 2.82 | [− 8.11;2.54] | 0.292 |
Length of ICU stay (for 10 days) | 0.39 | [− 0.23;1.01] | 0.208 |
Predicting post-traumatic stress disorder in follow-up | |||
History of sleep disorders | 8.36 | [− 1.60;18.4] | 0.100 |
Acute respiratory distress syndrome | 0.059 | ||
Mild | Reference | Reference | |
Moderate | 0.55 | [− 7.13;8.17] | |
Severe | 9.81 | [1.06;18.5] | |
Cumulative dose of morphine (for 1000 units) | 0.21 | [− 1.77;2.17] | 0.826 |
Cumulative dose of midazolam (for 100 units) | 0.16 | [− 0.04;0.35] | 0.103 |
Cumulative dose of clonidine (for 1 unit) | 0.93 | [− 1.14;3.01] | 0.363 |
Maximal dose of norepinephrine | 5.71 | [− 9.65;21.0] | 0.449 |
Length of ICU stay (for 10 days) | 1.54 | [− 0.37;3.42] | 0.109 |